Baseline variables | Treatment-placebo (n = 16) | Placebo-treatment sequence (n = 8) | Total (N = 24) | |||
---|---|---|---|---|---|---|
M | SD | M | SD | M | SD | |
Age (years) | 43.13 | 10.67 | 46.75 | 13.13 | 44.33 | 11.39 |
Gender (female) | 7 (43.75%) | Â | 3 (37.50%) | Â | 10 (41.66%) | Â |
Injury type (TBI) | 14 (87.50%) | Â | 5 (62.50%) | Â | 19 (79.17%) | Â |
BFI | 5.33 | 1.75 | 6.75 | 0.85 | 5.81 | 1.64 |
FSS | 5.07 | 1.27 | 5.85 | 0.64 | 5.33 | 1.15 |
ESS | 7.69 | 3.89 | 10.25 | 5.20 | 8.54 | 4.43 |
PSQI | 7.81 | 4.09 | 9.38 | 4.03 | 8.33 | 4.05 |
ISI | 13.19 | 5.72 | 13.25 | 6.80 | 13.21 | 5.95 |
HADS (Depression) | 6.31 | 3.40 | 8.25 | 3.01 | 6.96 | 3.34 |
PVT: mean RTb | 345.82 | 89.11 | 332.68 | 62.96 | 321.58 | 52.41 |
PVT: Fastest 10% RTb | 255.07 | 41.58 | 252.63 | 28.69 | 245.50 | 27.32 |
POPS | -0.12 | 0.53 | -0.50 | 0.44 | -0.24 | 0.52 |
Productive Activity (%) | 85.82 | 12.28 | 84.17 | 9.67 | 85.16 | 10.96 |
Sleep onsetc,d | 22.90 | 0.87 | 23.62 | 0.98 | 23.13 | 0.95 |
Sleep offsetc,d | 30.95 | 0.64 | 31.12 | 1.05 | 31.00 | 0.77 |
SOLc | 16.40 | 12.66 | 21.19 | 12.66 | 17.91 | 12.52 |
WASOc | 45.38 | 20.32 | 40.25 | 13.18 | 43.76 | 18.15 |
TSTc | 437.29 | 31.73 | 426.73 | 66.72 | 433.96 | 43.97 |
Sleep efficiency (%)c | 86.40 | 4.67 | 85.67 | 5.06 | 86.17 | 4.66 |